Skip to main content
    M

    Matinas BioPharma Holdings Inc (MTNB)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • AMEX

    $2.50
    -0.24 (-8.76%)

    Market Cap: $2.45M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    85%(29/34)
    Avg Surprise
    -7.08%
    Streak
    1 Q
    PeriodReportedEst.SurpriseB/MYoY
    Jun 26
    Reported Aug 13
    		$-0.21N/AN/ABeat+79.6%
    Mar 26
    Reported May 8
    		$-0.30N/AN/ABeat+9.1%
    Dec 25
    Reported Mar 31
    		$-4.48$0.00N/ABeat-455.7%
    Sep 25
    Reported Nov 10
    		$-0.40$0.00N/ABeat+52.9%
    Jun 25
    Reported Aug 14
    		$-1.03$0.00N/ABeat-5050.0%
    Mar 25
    Reported Apr 15
    		$-0.33N/A+57.69%Beat+78.0%
    Dec 24
    Reported Mar 26
    		$-0.81$-0.78-3.28%Miss-3928.0%
    Sep 24
    Reported Nov 13
    		$-0.85$-1.05+19.05%Beat+43.3%
    Jun 24
    Reported Aug 14
    		$-0.02N/A+98.00%Beat+98.7%
    Mar 24
    Reported May 9
    		$-1.50$-1.50+0.00%Beat+0.0%
    Dec 23
    Reported Mar 27
    		$-0.02$-0.03+33.33%Beat+0.0%
    Sep 23
    Reported Nov 8
    		$-1.50$-1.50+0.00%Beat+0.0%
    Jun 23
    Reported Aug 9
    		$-1.50$-1.50+0.00%Beat+0.0%
    Mar 23
    Reported May 10
    		$-1.50$-1.50+0.00%Beat+0.0%
    Dec 22
    Reported Mar 15
    		$-0.02$-0.03+33.33%Beat+33.3%
    Sep 22
    Reported Nov 2
    		$-1.50$-1.50+0.00%Beat+0.0%
    Jun 22
    Reported Aug 11
    		$-1.50$-1.50+0.00%Beat-50.0%
    Mar 22
    Reported May 12
    		$-1.50$-1.25-20.00%Miss+0.0%
    Dec 21
    Reported Mar 8
    		$-0.03$-0.03+0.00%Beat+0.0%
    Sep 21
    Reported Nov 8
    		$-1.50$-1.50+0.00%Beat+0.0%
    Jun 21
    Reported Aug 10
    		$-1.00$-1.75+42.86%Beat+33.3%
    Mar 21
    Reported May 10
    		$-1.50$-1.50+0.00%Beat-4900.0%
    Dec 20
    Reported Mar 29
    		$-0.03$-0.03+0.00%Beat+98.4%
    Sep 20
    Reported Nov 6
    		$-1.50$-1.67+10.18%Beat+0.0%
    Jun 20
    Reported Aug 10
    		$-1.50$-1.50+0.00%Beat+6.3%
    Mar 20
    Reported May 11
    		$-0.03$-0.03+0.00%Beat+98.5%
    Dec 19
    Reported Mar 9
    		$-1.83$-1.83+0.00%Beat-6000.0%
    Sep 19
    Reported Nov 13
    		$-1.50$-2.00+25.00%Beat+0.0%
    Jun 19
    Reported Aug 13
    		$-1.60$-2.00+20.00%Beat+20.0%
    Mar 19
    Reported Apr 2
    		$-2.00$-1.50-33.33%Miss+20.0%
    Dec 18
    Reported Dec 31
    		$-0.03$-0.03+0.00%Beat+25.0%
    Sep 18
    Reported Nov 12
    		$-1.50$-2.00+25.00%Beat+25.0%
    Jun 18
    Reported Aug 10
    		$-2.00$-2.00+0.00%Beat+0.0%
    Mar 18
    Reported May 10
    		$-2.50$-2.00-25.00%Miss+80.0%
    Dec 17
    Reported Mar 26
    		$-0.04$-0.04+0.00%Beat-33.3%
    Sep 17
    Reported Nov 15
    		$-2.00$-2.33+14.16%Beat-
    Jun 17
    Reported Aug 8
    		$-2.00$-2.33+14.16%Beat-
    Mar 17
    Reported Apr 3
    		$-12.50$-1.75-614.29%Miss-
    Dec 16
    Reported Mar 31
    		$-0.03N/A+62.50%Beat-

    Key Metrics

    Valuation
    P/E Ratio-0.03EV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-141.20%ROIC-294.64%
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio0.85xQuick Ratio0.85x
    Trading Statistics
    Beta2.08Avg Volume451.91K
    52-Week High$27.9052-Week Low$2.26

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$2.71
    SMA 20$2.64
    SMA 50$2.99
    SMA 200$7.50
    EMA 10$2.71
    EMA 20$2.74
    EMA 50$3.45
    EMA 200$7.49

    MACD

    Line: -0.10Signal: -0.15Hist: 0.05

    ADX

    ADX: 55.6+DI: 8.8-DI: 1.8

    Aroon & PSAR

    Aroon Up80.0
    Aroon Down20.0
    PSAR$1.37

    Bollinger Bands

    Upper Band$3.00
    Lower Band$2.28
    %B Position2713%(Upper)
    Band Width0.30

    RSI (14-Day)

    Neutral
    42.6

    Momentum Oscillators

    Stoch %K85.1
    Stoch %D87.6
    Williams %R-21.7
    ROC (10d)-13.2%
    Momentum-0.38
    CCI (20d)44.9
    MFI (14d)69.4

    Volatility Measures

    ATR (14d)$1.36(54.5%)
    StdDev (20d)0.18
    Hist Vol109.9%(High)

    Volume Flow

    VWAP$2.56
    OBV225.0M
    AD Line50.4B
    CMF (20d)239.270

    Volume Metrics

    Avg Vol (20d)326.8K
    Vol Ratio0.2x(Low)
    VWMA (20d)$2.61

    Pivot Points

    R3$2.98
    R2$2.91
    R1$2.83
    Pivot Point$2.76
    S1$2.68
    S2$2.61
    S3$2.53

    Advanced Oscillators

    TSI-8.24
    Ultimate Osc69.5
    KST-53.90

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$0$0$0$0$0$0$0$0$-1,096,000$0
    Cost of Revenue$0$0$-85,000$0$0$0N/A$0$0$0$3.67M$0
    Gross Profit$0$0$85,000$0$0$0N/A$0$0$0$-3,665,000$0
    Operating Expenses$1.55M$1.94M$1.56M$1.58M$1.84M$1.95M$8.47M$4.38M$5.84M$5.90M$5.89M$6.13M
    R&D$0$0$0$0$0$85,000$2.38M$2.24M$3.37M$3.45M$3.67M$3.29M
    SG&A$1.55M$1.94M$1.60M$1.58M$1.84M$1.86M$1.66M$2.14M$2.47M$2.46M$2.22M$2.84M
    Operating Income$-1,555,000$-1,936,000$-1,600,000$-1,577,000$-1,837,000$-1,946,000$-8,471,000$-4,381,000$-5,839,000$-5,902,000$-5,887,000$-6,134,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$0$0$316,000$0$3.41M$0$0$0$0$0$0$0
    Income Before Tax$-1,326,000$-1,921,000$-1,916,000$-1,532,000$-5,245,000$-1,656,000$-8,209,000$-4,381,000$-5,839,000$-5,902,000$-5,314,000$-6,055,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-1,326,000$-1,921,000$-1,912,000$-1,532,000$-5,245,000$-1,656,000$-8,433,000$-4,275,000$-5,719,000$-5,824,000$-5,314,000$-6,055,000
    EBITDA$-1,322,000$-1,847,000$-1,526,000$-1,533,000$-5,123,000$-1,528,000$-7,513,000$-4,287,000$-5,932,000$-5,644,000$-5,541,000$-5,800,000
    EBIT$-1,326,000$-1,921,000$-1,953,000$-1,532,000$-5,245,000$-1,656,000$-8,209,000$-4,381,000$-5,839,000$-5,902,000$-5,798,000$-6,055,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about MTNB

    News

    Matinas BioPharma Holdings, Inc. Revenue Breakdown – GETTEX:6LJ

    This page on TradingView provides financial information for Matinas BioPharma Holdings, Inc. (GETTEX:6LJ). It focuses on the company's revenue breakdown, including segments and regional performance...

    TradingView•10/2/26•Neutral

    Enterprise value to revenue forward of Matinas BioPharma Holdings, Inc. – FWB:6LJ

    The article provides financial information for Matinas BioPharma Holdings, Inc. (FWB:6LJ) on the Frankfurt Stock Exchange. It specifically mentions the "Enterprise value to revenue forward" metric for the company....

    TradingView•9/30/26•Neutral

    Book value per share of Matinas BioPharma Holdings, Inc. – MUN:6LJ

    This article provides financial information for Matinas BioPharma Holdings, Inc. (MUN:6LJ) on TradingView, specifically focusing on its book value per share. The content is presented as a financial data page...

    TradingView•9/30/26•Neutral

    Price to sales forward of Matinas BioPharma Holdings, Inc. – MUN:6LJ

    This article provides the "Price to sales forward" value for Matinas BioPharma Holdings, Inc. (MUN:6LJ), a company listed on the Munich Stock Exchange. The data is presented within the context of TradingView's financial...

    TradingView•9/30/26•Neutral

    Form DEF 14A Matinas BioPharma Holdings Inc For: 29 September By Investing.com

    This article announces the filing of Form DEF 14A by Matinas BioPharma Holdings Inc. for September 29. The filing is an important regulatory document typically related to proxy statements for shareholder meetings.

    Investing.com Canada•9/29/26•Neutral

    MTNB Valuation and Fair Value

    P/E
    -0.0x
    PEG
    0.0x
    P/B
    0.6x
    See GNG's fair value

    MTNB Profitability: Margins, ROIC and FCF

    Operating margin
    0.0%
    Net margin
    0.0%
    ROIC
    -294.6%
    ROE
    -141.2%

    MTNB Competitors

    CompanyTicker
    Kairos Pharma, Ltd.KAPA
    GeoVax Labs IncGOVX
    Biomotion Sciences Ordinary SharesSLXN
    Elevai Labs, Inc. Common StockELAB
    iSpecimen IncISPC
    Flora Growth CorpFLGC
    Nexalin Technology Inc.NXL
    Virax Biolabs Group Limited Ordinary SharesVRAX

    Sector: Healthcare

    MTNB Bull Case vs Bear Case

    Bear case

    • MTNB beat EPS estimates in 37.5% of its last 8 reported quarters.
    • MTNB's quarterly revenue changed -100.0% year over year.

    MTNB Earnings: Beat Rate and Next Report

    Beat rate
    3 of 8 quarters (37.5%)
    Average surprise
    34.3%

    Frequently Asked Questions About MTNB

    Does MTNB pay dividends?

    Matinas BioPharma Holdings Inc (MTNB) does not currently pay a regular dividend.

    What is MTNB's market cap?

    Matinas BioPharma Holdings Inc (MTNB) has a market capitalization of $2.45M with a current stock price of $2.50.

    Related stocks

    Sector: Healthcare

    All stocks starting with M

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In